Frailty's Toll: How Frailty Affects Survival in Elderly Hypertensive Patients

Recent research has shown that frailty significantly impacts the survival of elderly individuals with hypertension. Using data from the Chinese Longitudinal Healthy Longevity Survey, scientists evaluated frailty through a 36-item index, classifying participants into various frailty levels. Results indicate that as frailty increases, survival rates decrease, even after adjusting for other health and lifestyle factors.

The research underscores the critical importance of early detection and intervention in managing frailty to improve life expectancy. Frailty, unlike many irreversible conditions, can often be mitigated with appropriate lifestyle and medical interventions. This highlights the potential for significant improvements in health outcomes by focusing on frailty in elderly care, particularly for those with hypertension.

Additionally, the study explores the nearly linear relationship between frailty and survival, revealing that higher frailty scores correspond to shorter life spans. This knowledge empowers healthcare providers to develop more targeted strategies to manage frailty and enhance longevity in the aging population.

Article Information

Association of frailty status with overall survival in elderly hypertensive patients: based on the Chinese Longitudinal Healthy Longevity Survey

Published in BMC Public Health, Liying Li et al.

Abstract

Background

Hypertension and frailty often coexist in older people. The present study aimed to evaluate the association of frailty status with overall survival in elderly hypertensive patients, using data from the Chinese Longitudinal Healthy Longevity Survey.

Methods

A total of 10,493 elderly hypertensive patients were included in the present study (median age 87.0 years, 58.3% male). Frailty status was assessed according to a 36-item frailty index (FI), which divides elderly individuals into four groups: robustness (FI ≤ 0.10), pre-frailty (0.10 < FI ≤ 0.20), mild-frailty (0.20 < FI ≤ 0.30), and moderate-severe frailty (FI > 0.30). The study outcome was overall survival time. Accelerated failure time model was used to evaluate the association of frailty status with overall survival.

Results

During a period of 44,616.6 person-years of follow-up, 7327 (69.8%) participants died. The overall survival time was decreased with the deterioration of frailty status. With the robust group as reference, adjusted time ratios (TRs) were 0.84 (95% confidence interval [CI]: 0.80–0.87) for the pre-frailty group, 0.68 (95% CI: 0.64–0.72) for the mild frailty group, and 0.52 (95% CI: 0.48–0.56) for the moderate-severe frailty group, respectively. In addition, restricted cubic spline analysis revealed a nearly linear relationship between FI and overall survival (p for non-linearity = 0.041), which indicated the overall survival time decreased by 17% with per standard deviation increase in FI (TR = 0.83, 95% CI: 0.82–0.85). Stratified and sensitivity analyses suggested the robustness of the results.

Conclusions

The overall survival time of elderly hypertensive patients decreased with the deterioration of frailty status. Given that frailty is a dynamic and even reversible process, early identification of frailty and active intervention may improve the prognosis of elderly hypertensive patients.